Pharmaceuticals, Biotechnology and Life Sciences
All director nominees reelected for the coming yearAll other proposals also approved by shareholders TORONTO and CHICAGO, Sept. 15, 2022…
WOBURN, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) — Yield10 Bioscience, Inc. (Nasdaq:YTEN) (“Yield10” or the “Company”), an agricultural bioscience company,…
SOUTH SAN FRANCISCO, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage company developing transformational…
CAMBRIDGE, Mass., Sept. 14, 2022 (GLOBE NEWSWIRE) — Third Harmonic Bio, Inc. (Nasdaq: THRD), a clinical-stage biopharmaceutical company developing a…
LA JOLLA, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
Qualigen Therapeutics, Inc. Receptors for cardiac and neurological function Qualigen Therapeutics, Inc. Vehicle BIW QN-302 Qualigen Therapeutics, Inc. Normalised heart…
INDIANAPOLIS, Sept. 13, 2022 (GLOBE NEWSWIRE) — POINT Biopharma Global Inc. (NASDAQ: PNT) (the “Company” or “POINT”), a company accelerating…
LA JOLLA, Calif., Sept. 13, 2022 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market…
NGM120 is a novel antagonist antibody that binds GFRAL and inhibits GDF15 signaling for the potential treatment of cancerNGM120 has…
VANCOUVER, British Columbia, Sept. 13, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader…